Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Active not recruiting 4Completed 3Terminated 2Recruiting 2Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 8Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Breast 1

Conditions

Breast Neoplasms 1320Neoplasms 983Carcinoma, Non-Small-Cell Lung 858Prostatic Neoplasms 723Colorectal Neoplasms 662Lung Neoplasms 548Leukemia, Myeloid, Acute 475Neoplasm Metastasis 431Pancreatic Neoplasms 418Carcinoma, Hepatocellular 406Multiple Myeloma 397Ovarian Neoplasms 391Stomach Neoplasms 378Recurrence 365Squamous Cell Carcinoma of Head and Neck 325Melanoma 293Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 271Head and Neck Neoplasms 263Glioblastoma 263Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 233Lymphoma 227Esophageal Neoplasms 222Rectal Neoplasms 221Sarcoma 211Carcinoma, Renal Cell 203Colonic Neoplasms 193Lymphoma, Large B-Cell, Diffuse 191

Interventions

Octreotide 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Pancreatic Intraductal Neoplasms × Clear all
NCT07213791 2026-06-04

FiREBOLT

Eli Lilly and Company

Phase 1 Recruiting
241 enrolled
BreastGastrointestinalGynecologic

Pancreatic Intraductal Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT07262957 2025-12-22

PANENCA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Recruiting
400 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Duodenal Neoplasms, Fistula, Pancreatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡